Plasma concentrations and bioavailability of propranolol by oral, rectal and intravenous administration in man

Eight normal male volunteers received 80 mg doses of propranolol by the oral and rectal routes and 2·2 mg by intravenous administration in a crossover fashion. Plasma concentrations of propranolol were measured by a gas chromatographic method using an electron capture detector. Individual subject co...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biopharmaceutics & drug disposition 1986-11, Vol.7 (6), p.559-566
Hauptverfasser: Cid, Edison, Mella, Fernando, Lucchini, Leonardo, Cárcamo, Martín, Monasterio, José
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 566
container_issue 6
container_start_page 559
container_title Biopharmaceutics & drug disposition
container_volume 7
creator Cid, Edison
Mella, Fernando
Lucchini, Leonardo
Cárcamo, Martín
Monasterio, José
description Eight normal male volunteers received 80 mg doses of propranolol by the oral and rectal routes and 2·2 mg by intravenous administration in a crossover fashion. Plasma concentrations of propranolol were measured by a gas chromatographic method using an electron capture detector. Individual subject concentration–time data were analysed and results indicated that the data fit a two compartment model with first order absorption. An approximately two‐fold higher plasma propranolol concentration was observed after rectal administration as compared with oral dosing. Statistical analysis of the difference in the total AUCs indicates a significantly higher bioavailability of propranolol administered by the rectal route. The reduced bioavailability after oral administration indicates a substantial first pass effect but that it is possible to bypass the liver, at least partially, by giving the drug rectally to man.
doi_str_mv 10.1002/bdd.2510070605
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77293271</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>77293271</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4075-e4e1734fc582950713f8d7803470516786470fcdc74a70fd4bbed88e48edc5c53</originalsourceid><addsrcrecordid>eNqFUEuPFCEYJEazzo5evZn0wXjaHqGBhj66sw-N6yNRozfyNdAJSsMIPbvOv5dxOmP25IkK9fgqhdAzglcE4-ZVb8yq4QUK3GL-AC0I7roaS_L9IVpgwpq6EbJ5jE5z_oExbgkhJ-iEykYyyRcofPKQR6h0DNqGKcHkYsgVBFP1LsItOA-9827aVXGoNiluEoToo6_68pPAn1XJ6gn8X4vbJ9zaELclwowuuDxHFqoaITxBjwbw2T6d3yX6enX5Zf2mvvl4_Xb9-qbWDAteW2aJoGzQXDYdx4LQQRohMWUCc9IK2RYwaKMFgwIM63trpLRMWqO55nSJXh5yS-NfW5snNbqsrfcQbCmnhGg62pTcJVodhDrFnJMd1Ca5EdJOEaz2A6sysPo3cDE8n5O3_WjNUT4vWvgXMw9Zgx_KXNrlo0wSwoTc3-0Osjvn7e4_R9X5xcW9CvXBW9a1v49eSD9VK6jg6tuHa_Ue88_n8t1aUfoHOlykCQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77293271</pqid></control><display><type>article</type><title>Plasma concentrations and bioavailability of propranolol by oral, rectal and intravenous administration in man</title><source>MEDLINE</source><source>Wiley Journals</source><creator>Cid, Edison ; Mella, Fernando ; Lucchini, Leonardo ; Cárcamo, Martín ; Monasterio, José</creator><creatorcontrib>Cid, Edison ; Mella, Fernando ; Lucchini, Leonardo ; Cárcamo, Martín ; Monasterio, José</creatorcontrib><description>Eight normal male volunteers received 80 mg doses of propranolol by the oral and rectal routes and 2·2 mg by intravenous administration in a crossover fashion. Plasma concentrations of propranolol were measured by a gas chromatographic method using an electron capture detector. Individual subject concentration–time data were analysed and results indicated that the data fit a two compartment model with first order absorption. An approximately two‐fold higher plasma propranolol concentration was observed after rectal administration as compared with oral dosing. Statistical analysis of the difference in the total AUCs indicates a significantly higher bioavailability of propranolol administered by the rectal route. The reduced bioavailability after oral administration indicates a substantial first pass effect but that it is possible to bypass the liver, at least partially, by giving the drug rectally to man.</description><identifier>ISSN: 0142-2782</identifier><identifier>EISSN: 1099-081X</identifier><identifier>DOI: 10.1002/bdd.2510070605</identifier><identifier>PMID: 3828485</identifier><identifier>CODEN: BDDID8</identifier><language>eng</language><publisher>New York: John Wiley &amp; Sons, Ltd</publisher><subject>Administration, Oral ; Administration, Rectal ; Adult ; Bioavailability ; Biological and medical sciences ; Biological Availability ; Cardiovascular system ; First pass effect ; Humans ; Infusions, Intravenous ; Kinetics ; Male ; Medical sciences ; Miscellaneous ; Pharmacokinetics ; Pharmacology. Drug treatments ; Propranolol ; Propranolol - administration &amp; dosage ; Propranolol - blood ; Rectal absorption</subject><ispartof>Biopharmaceutics &amp; drug disposition, 1986-11, Vol.7 (6), p.559-566</ispartof><rights>Copyright © 1986 John Wiley &amp; Sons, Inc.</rights><rights>1987 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4075-e4e1734fc582950713f8d7803470516786470fcdc74a70fd4bbed88e48edc5c53</citedby><cites>FETCH-LOGICAL-c4075-e4e1734fc582950713f8d7803470516786470fcdc74a70fd4bbed88e48edc5c53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fbdd.2510070605$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fbdd.2510070605$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=8114781$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3828485$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cid, Edison</creatorcontrib><creatorcontrib>Mella, Fernando</creatorcontrib><creatorcontrib>Lucchini, Leonardo</creatorcontrib><creatorcontrib>Cárcamo, Martín</creatorcontrib><creatorcontrib>Monasterio, José</creatorcontrib><title>Plasma concentrations and bioavailability of propranolol by oral, rectal and intravenous administration in man</title><title>Biopharmaceutics &amp; drug disposition</title><addtitle>Biopharm. Drug Dispos</addtitle><description>Eight normal male volunteers received 80 mg doses of propranolol by the oral and rectal routes and 2·2 mg by intravenous administration in a crossover fashion. Plasma concentrations of propranolol were measured by a gas chromatographic method using an electron capture detector. Individual subject concentration–time data were analysed and results indicated that the data fit a two compartment model with first order absorption. An approximately two‐fold higher plasma propranolol concentration was observed after rectal administration as compared with oral dosing. Statistical analysis of the difference in the total AUCs indicates a significantly higher bioavailability of propranolol administered by the rectal route. The reduced bioavailability after oral administration indicates a substantial first pass effect but that it is possible to bypass the liver, at least partially, by giving the drug rectally to man.</description><subject>Administration, Oral</subject><subject>Administration, Rectal</subject><subject>Adult</subject><subject>Bioavailability</subject><subject>Biological and medical sciences</subject><subject>Biological Availability</subject><subject>Cardiovascular system</subject><subject>First pass effect</subject><subject>Humans</subject><subject>Infusions, Intravenous</subject><subject>Kinetics</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Miscellaneous</subject><subject>Pharmacokinetics</subject><subject>Pharmacology. Drug treatments</subject><subject>Propranolol</subject><subject>Propranolol - administration &amp; dosage</subject><subject>Propranolol - blood</subject><subject>Rectal absorption</subject><issn>0142-2782</issn><issn>1099-081X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1986</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUEuPFCEYJEazzo5evZn0wXjaHqGBhj66sw-N6yNRozfyNdAJSsMIPbvOv5dxOmP25IkK9fgqhdAzglcE4-ZVb8yq4QUK3GL-AC0I7roaS_L9IVpgwpq6EbJ5jE5z_oExbgkhJ-iEykYyyRcofPKQR6h0DNqGKcHkYsgVBFP1LsItOA-9827aVXGoNiluEoToo6_68pPAn1XJ6gn8X4vbJ9zaELclwowuuDxHFqoaITxBjwbw2T6d3yX6enX5Zf2mvvl4_Xb9-qbWDAteW2aJoGzQXDYdx4LQQRohMWUCc9IK2RYwaKMFgwIM63trpLRMWqO55nSJXh5yS-NfW5snNbqsrfcQbCmnhGg62pTcJVodhDrFnJMd1Ca5EdJOEaz2A6sysPo3cDE8n5O3_WjNUT4vWvgXMw9Zgx_KXNrlo0wSwoTc3-0Osjvn7e4_R9X5xcW9CvXBW9a1v49eSD9VK6jg6tuHa_Ue88_n8t1aUfoHOlykCQ</recordid><startdate>198611</startdate><enddate>198611</enddate><creator>Cid, Edison</creator><creator>Mella, Fernando</creator><creator>Lucchini, Leonardo</creator><creator>Cárcamo, Martín</creator><creator>Monasterio, José</creator><general>John Wiley &amp; Sons, Ltd</general><general>Wiley</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>198611</creationdate><title>Plasma concentrations and bioavailability of propranolol by oral, rectal and intravenous administration in man</title><author>Cid, Edison ; Mella, Fernando ; Lucchini, Leonardo ; Cárcamo, Martín ; Monasterio, José</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4075-e4e1734fc582950713f8d7803470516786470fcdc74a70fd4bbed88e48edc5c53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1986</creationdate><topic>Administration, Oral</topic><topic>Administration, Rectal</topic><topic>Adult</topic><topic>Bioavailability</topic><topic>Biological and medical sciences</topic><topic>Biological Availability</topic><topic>Cardiovascular system</topic><topic>First pass effect</topic><topic>Humans</topic><topic>Infusions, Intravenous</topic><topic>Kinetics</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Miscellaneous</topic><topic>Pharmacokinetics</topic><topic>Pharmacology. Drug treatments</topic><topic>Propranolol</topic><topic>Propranolol - administration &amp; dosage</topic><topic>Propranolol - blood</topic><topic>Rectal absorption</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cid, Edison</creatorcontrib><creatorcontrib>Mella, Fernando</creatorcontrib><creatorcontrib>Lucchini, Leonardo</creatorcontrib><creatorcontrib>Cárcamo, Martín</creatorcontrib><creatorcontrib>Monasterio, José</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biopharmaceutics &amp; drug disposition</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cid, Edison</au><au>Mella, Fernando</au><au>Lucchini, Leonardo</au><au>Cárcamo, Martín</au><au>Monasterio, José</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Plasma concentrations and bioavailability of propranolol by oral, rectal and intravenous administration in man</atitle><jtitle>Biopharmaceutics &amp; drug disposition</jtitle><addtitle>Biopharm. Drug Dispos</addtitle><date>1986-11</date><risdate>1986</risdate><volume>7</volume><issue>6</issue><spage>559</spage><epage>566</epage><pages>559-566</pages><issn>0142-2782</issn><eissn>1099-081X</eissn><coden>BDDID8</coden><abstract>Eight normal male volunteers received 80 mg doses of propranolol by the oral and rectal routes and 2·2 mg by intravenous administration in a crossover fashion. Plasma concentrations of propranolol were measured by a gas chromatographic method using an electron capture detector. Individual subject concentration–time data were analysed and results indicated that the data fit a two compartment model with first order absorption. An approximately two‐fold higher plasma propranolol concentration was observed after rectal administration as compared with oral dosing. Statistical analysis of the difference in the total AUCs indicates a significantly higher bioavailability of propranolol administered by the rectal route. The reduced bioavailability after oral administration indicates a substantial first pass effect but that it is possible to bypass the liver, at least partially, by giving the drug rectally to man.</abstract><cop>New York</cop><pub>John Wiley &amp; Sons, Ltd</pub><pmid>3828485</pmid><doi>10.1002/bdd.2510070605</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0142-2782
ispartof Biopharmaceutics & drug disposition, 1986-11, Vol.7 (6), p.559-566
issn 0142-2782
1099-081X
language eng
recordid cdi_proquest_miscellaneous_77293271
source MEDLINE; Wiley Journals
subjects Administration, Oral
Administration, Rectal
Adult
Bioavailability
Biological and medical sciences
Biological Availability
Cardiovascular system
First pass effect
Humans
Infusions, Intravenous
Kinetics
Male
Medical sciences
Miscellaneous
Pharmacokinetics
Pharmacology. Drug treatments
Propranolol
Propranolol - administration & dosage
Propranolol - blood
Rectal absorption
title Plasma concentrations and bioavailability of propranolol by oral, rectal and intravenous administration in man
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T12%3A54%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Plasma%20concentrations%20and%20bioavailability%20of%20propranolol%20by%20oral,%20rectal%20and%20intravenous%20administration%20in%20man&rft.jtitle=Biopharmaceutics%20&%20drug%20disposition&rft.au=Cid,%20Edison&rft.date=1986-11&rft.volume=7&rft.issue=6&rft.spage=559&rft.epage=566&rft.pages=559-566&rft.issn=0142-2782&rft.eissn=1099-081X&rft.coden=BDDID8&rft_id=info:doi/10.1002/bdd.2510070605&rft_dat=%3Cproquest_cross%3E77293271%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=77293271&rft_id=info:pmid/3828485&rfr_iscdi=true